Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HT 101

Next Previous
Drug Profile

HT 101

Alternative Names: HT-101

Latest Information Update: 27 Nov 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Suzhou Hepa Thera Biopharmaceutical
  • Class Amides; Amino sugars; Antivirals; Small interfering RNA
  • Mechanism of Action RNA interference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Hepatitis B

Most Recent Events

  • 05 Nov 2025 Phase-II clinical trials in Hepatitis B (Combination therapy) in China (SC) (NCT07245953)
  • 15 Nov 2024 Safety, efficacy and pharmacokinetics data from a phase-I clinical trials in Hepatitis B presented at the Liver Meeting 2024: 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2024)
  • 05 Jun 2024 Efficacy and adverse events data from a phase Ib trial in Hepatitis B presented at the European Association for the Study of the Liver Congress 2024 (EASL-2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top